AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Injection Drug Use

U.S. Preventive Services Task Force Seeks Comment on its Draft Recommendation Statement on Hepatitis B Screening for High-Risk Adults

US PSTF Logo

This week, the U.S. Preventive Services Task Force  (USPSTF) issued its draft recommendation statement pertaining to hepatitis B screening, recommending screening people who are at high risk for hepatitis B infection. Before finalizing the recommendation, the USPSTF is inviting public comments on the draft statement until March 10, 2014. The Task Force is an independent group…

Scientists Discover Hepatitis C Virus Can Remain Infectious Outside of the Body for Up to 6 Weeks

Ronald Valdiserri

A recent study by researchers from the Yale Schools of Medicine and Public Health revealed that the hepatitis C virus (HCV) can remain infectious for up to 6 weeks on surfaces at room temperature—resulting in a much longer period for potential transmission than was previously appreciated.  Prior to this study, scientists believed that HCV could…

World AIDS Day 2013—Addiction Treatment Supports AIDS Treatment

NIDA displays panels from the AIDS Memorial Quilt

December 1 is World AIDS Day. At NIDA, we always stress the principle that drug abuse treatment is AIDS prevention, because of the close links that exist between drug abuse and the spread of HIV.  Injection drug use alone contributed to more than 7% of new infections in 2011, although the population of people who…

Together on the Pathways to Wellness: Recovery and Efforts to Strengthen Viral Hepatitis Services

Ronald Valdiserri

Throughout September’s observance of National Recovery Month, individuals, organizations, and communities across the nation celebrated recovery from mental health issues and addiction challenges. Given the significant role that drug-using behaviors can play in the transmission of viral hepatitis, and the fact that alcohol intake often worsens liver disease among persons with chronic viral hepatitis, National Recovery…

CDC Recommends PrEP for Injection Drug Users

Jonathan Mermin

The Center for Disease Control and Prevention (CDC) today published in the weekly Morbidity and Mortality Weekly Report interim guidance for the use of Preexposure Prophylaxis (PrEP) for the prevention of HIV infection among Injecting Drug Users (IDUs). Results from a randomized controlled trial in Bangkok, Thailand, of a daily oral dose of 300 mg…

Study finds first evidence that PrEP can reduce HIV risk among people who inject drugs

CDC Logo

Daily HIV medications now proven to prevent HIV among all groups at high risk A daily dose of a medication used to treat HIV infection reduced the risk of HIV acquisition among people who inject drugs by 49 percent. Those who took the medication most consistently had even higher levels of protection, according to a…

Hepatitis C Infection Among Young Injection Drug Users: Addressing an Emerging Trend

Hepatitis C Report Cover

In recent years, there has been an emerging epidemic of hepatitis C virus (HCV) infection among young injection drug users (IDU) in rural and suburban settings. Early this spring, the U.S. Department of Health and Human Services convened a multidisciplinary technical consultation to discuss the existing evidence and to identify and define priorities for the…

NIDA Research Seeks to Reduce Viral Hepatitis Caused by Drug Use Behaviors

Compton & Khalsa

Hepatitis C virus (HCV) is the leading cause of liver failure and liver transplantation in the United States and people who inject drugs (PWID) are particularly susceptible to this disease with as many as 70% or more of this population testing positive for the virus. To make matters worse, PWID enjoy little if any consistent…

Page 1 of 3123